Circadian variation of mineral and bone parameters in end-stage renal disease

被引:26
|
作者
Trivedi, Hariprasad [1 ]
Szabo, Aniko [2 ]
Zhao, Shi [2 ]
Cantor, Tom [3 ]
Raff, Hershel [4 ,5 ]
机构
[1] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA
[3] Scantibodies Lab Inc, Santee, CA USA
[4] Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA
[5] Aurora St Lukes Med Ctr, Aurora Res Inst, Endocrine Res Lab, Milwaukee, WI USA
基金
美国国家卫生研究院;
关键词
Phosphate; Calcium; Parathyroid hormone; Circadian variation; End stage renal disease; VITAMIN-D DEFICIENCY; PLASMA PHOSPHATE; HEMODIALYSIS-PATIENTS; MORTALITY; RHYTHM; SUPPLEMENTATION; ERGOCALCIFEROL; PHOSPHORUS; METABOLISM; EXCRETION;
D O I
10.1007/s40620-014-0124-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Mineral and bone parameters are actively managed in end-stage renal disease (ESRD). However, whether these undergo circadian variation is not known. We investigated the circadian variation of mineral and bone parameters in patients on long-term hemodialysis. Methods Seventeen ESRD patients on long-term hemodialysis and eight volunteers without kidney disease were enrolled. Subjects had all medications that affect calcium-phosphate-parathyroid hormone balance (phosphate binders, vitamin D analogues, and calcimimetics) discontinued. Thereafter, for a period of 5 days, subjects consumed a diet controlled in calcium (1,200 mg per day) and phosphorus (1,000 mg per day) content. On the sixth day (a non-dialysis day for the ESRD patients), enrollees underwent twelve 2-h blood draws for phosphate, ionized calcium, parathyroid hormone (PTH), total 25-hydroxy vitamin D (25OHD), and fibroblast growth factor-23 (FGF-23). Results In the ESRD patients plasma phosphate demonstrated significant circadian variation (P < 0.00001). The peak occurred around 3: 30 am and nadir occurred around 11:00 am. Ionized calcium (P = 0.0036), PTH (P = 0.0004) and 25OHD (P = 0.009) also varied significantly during the circadian period; for ionized calcium peak and nadir occurred around 12:15 pm and 8:00 pm, parathyroid hormone 5:45 pm and 10:15 am, and 25OHD 9:45 am and 4:00 pm respectively. FGF-23 did not show a significant circadian variation. Only phosphate (P < 0.0001) and PTH (P = 0.00008) demonstrated circadian variation in the control group. Conclusions Blood concentrations of phosphate, calcium, PTH and 25-hydroxy vitamin D, exhibit a circadian variation in patients with ESRD. Knowledge of these phenomena is pertinent for the interpretation of clinical testing.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 50 条
  • [1] Circadian variation of mineral and bone parameters in end-stage renal disease
    Hariprasad Trivedi
    Aniko Szabo
    Shi Zhao
    Tom Cantor
    Hershel Raff
    Journal of Nephrology, 2015, 28 : 351 - 359
  • [2] Bone and mineral metabolism in childhood end-stage renal disease
    Salusky, IB
    PEDIATRIC CLINICS OF NORTH AMERICA, 1995, 42 (06) : 1531 - &
  • [3] Bone mineral density and mortality in end-stage renal disease patients
    Iseri, Ken
    Dai, Lu
    Chen, Zhimin
    Qureshi, Abdul Rashid
    Brismar, Torkel B.
    Stenvinkel, Peter
    Lindholm, Bengt
    CLINICAL KIDNEY JOURNAL, 2020, 13 (03) : 307 - 321
  • [4] Bone Mineral Density in Kuwaiti Patients with End-Stage Renal Disease
    Gupta, Renu
    Mohammed, Ahmed M.
    Alenizi, Eman K.
    Ben Nekhi, Abdulmohsen
    MEDICAL PRINCIPLES AND PRACTICE, 2010, 20 (02) : 156 - 158
  • [5] Radiographic manifestations of abnormal bone and mineral metabolism in end-stage renal disease
    Koratala, Abhilash
    Lappot, Joan Morales
    Kazory, Amir
    CLINICAL CASE REPORTS, 2019, 7 (03): : 589 - 590
  • [6] Regional variation in end-stage renal disease
    Usami, T
    Sato, R
    Yoshida, A
    Kimura, G
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (03): : 343 - 346
  • [7] Managing mineral balance in end-stage renal disease
    Ritz, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : I1 - I3
  • [8] Association between bone mineral metabolism and vascular calcification in end-stage renal disease
    Louise Aaltonen
    Niina Koivuviita
    Marko Seppänen
    Heikki Kröger
    Xiaoyu Tong
    Eliisa Löyttyniemi
    Kaj Metsärinne
    BMC Nephrology, 23
  • [9] Association between bone mineral metabolism and vascular calcification in end-stage renal disease
    Aaltonen, Louise
    Koivuviita, Niina
    Seppanen, Marko
    Kroger, Heikki
    Tong, Xiaoyu
    Loyttyniemi, Eliisa
    Metsarinne, Kaj
    BMC NEPHROLOGY, 2022, 23 (01)
  • [10] Bone mineral density in end-stage renal disease patients is a predictor of cardiovascular mortality
    Mazurenko, S. O.
    Enkin, A. A.
    Vasiliev, A. N.
    BONE, 2011, 48 : S200 - S200